GeoVax Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials
14 mars 2022 09h00 HE
|
GeoVax, Inc.
Comparative Trial Against Pfizer/BioNTech Vaccine Among Immunocompromised PatientsBooster to Pfizer/BioNTech or Moderna Vaccines Among Healthy PatientsATLANTA, GA, March 14, 2022 (GLOBE NEWSWIRE) --...
Indian Clinical Trials Market Outlook to 2030 - Featuring Key Players Iqvia Holdings, Icon plc, PRA Health Sciences, Inc. and Syngene International Among Others
11 mars 2022 07h13 HE
|
Research and Markets
Dublin, March 11, 2022 (GLOBE NEWSWIRE) -- The "Indian Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design...
World In-Silico Clinical Trials Market Research Report 2022-2030: Focus on Oncology, Infectious Disease, Hematology, Cardiology, Dermatology, Neurology, & Diabetes
09 mars 2022 07h38 HE
|
Research and Markets
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials Market Size, Share & Trends Analysis Report by Therapeutic Area (Oncology, Infectious Diseases), by Phase (Phase I, II,...
Adaptive Research and UBERDOC Announce Collaboration to Expand Clinical Trial Access to Physicians and Patients
08 mars 2022 08h00 HE
|
Adaptive Research Inc
SAN FRANCISCO, March 08, 2022 (GLOBE NEWSWIRE) -- Adaptive Research, an integrated clinical trial site organization with a unique purpose to democratize clinical trials by integrating community...
European Union and United Kingdom Clinical Trial Agreements Drafting and Negotiating Training Course, May 13th, 2022 (Virtual)
08 mars 2022 04h43 HE
|
Research and Markets
Dublin, March 08, 2022 (GLOBE NEWSWIRE) -- The "Drafting and Negotiating Clinical Trial Agreements Training Course" training has been added to ResearchAndMarkets.com's offering. This intensive and...
Axiom Exhibiting at Clinical Trial Supply New England 2022
07 mars 2022 10h32 HE
|
Axiom Real-Time Metrics Inc
TORONTO, March 07, 2022 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
07 mars 2022 06h00 HE
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, March 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Worldwide Clinical Trial Management Systems Industry to 2027 - Featuring Advarra, ArisGlobal and DataTrak Among Others
28 févr. 2022 07h33 HE
|
Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trial Management Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight to 2028: Comprehensive Insight on 60 Transdermal Patch Available Commercially
23 févr. 2022 07h43 HE
|
Research and Markets
Dublin, Feb. 23, 2022 (GLOBE NEWSWIRE) -- The "Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The...
Non-alcoholic Steatohepatitis Clinical Trials Market Report 2022: Phase III Segment Dominated the Global Market in 2021
22 févr. 2022 05h08 HE
|
Research and Markets
Dublin, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The "Non-alcoholic Steatohepatitis Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, II, III, IV), by Study Design...